Lexaria Bioscience Corp. (LEXXW)
- Previous Close
0.7100 - Open
0.7300 - Bid --
- Ask --
- Day's Range
0.7100 - 0.9747 - 52 Week Range
0.7100 - 0.9747 - Volume
263,457 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
lexariabioscience.comRecent News: LEXXW
Compare To: LEXXW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LEXXW
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-59.36%
Return on Equity (ttm)
-101.49%
Revenue (ttm)
404.73k
Net Income Avi to Common (ttm)
-5.44M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
4.79M
Total Debt/Equity (mrq)
2.42%
Levered Free Cash Flow (ttm)
-3.45M
Company Insights: LEXXW
LEXXW does not have Company Insights